HRSA Again Delays 340B Ceiling Price Rule, Points To Outstanding Questions

The Health Resources and Services Administration again pushed back implementing the 340B ceiling price and civil monetary penalty rule, saying there are still substantial questions about the rule and signaling the administration may be taking a broader overall look at the implementation of 340B drug discounts and how this rule fits in. The rule, finalized shortly before President Obama left office , deals with setting prices under the 340B drug discount program. It finalized the so-called “penny-pricing policy” and laid...